Darell D Bigner Selected Research

Glioma (Gliomas)

1/2022	Epigenetic STING silencing is developmentally conserved in gliomas and can be rescued by methyltransferase inhibition.
1/2019	Sensitive and rapid detection of TERT promoter and IDH mutations in diffuse gliomas.
1/2019	MGMT: Immunohistochemical Detection in High-Grade Astrocytomas.
1/2019	Improved efficacy against malignant brain tumors with EGFRwt/EGFRvIII targeting immunotoxin and checkpoint inhibitor combinations.
12/2018	Recurrent Glioblastoma Treated with Recombinant Poliovirus.
1/2018	Application of mutagen sensitivity assay in a glioma case-control study.
1/2018	A Rationally Designed Fully Human EGFRvIII:CD3-Targeted Bispecific Antibody Redirects Human T Cells to Treat Patient-derived Intracerebral Malignant Glioma.
1/2018	Adaptive Evolution of the GDH2 Allosteric Domain Promotes Gliomagenesis by Resolving IDH1R132H-Induced Metabolic Liabilities.
12/2017	Validation of an Immunohistochemistry Assay for Detection of CD155, the Poliovirus Receptor, in Malignant Gliomas.
1/2017	Mutant IDH1 Disrupts the Mouse Subventricular Zone and Alters Brain Tumor Progression.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Darell D Bigner Research Topics

Disease

142	Neoplasms (Cancer) 01/2021 - 01/2002
100	Glioma (Gliomas) 01/2022 - 01/2002
72	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 01/2004
45	Brain Neoplasms (Brain Tumor) 01/2019 - 11/2002
13	Medulloblastoma 09/2017 - 07/2002
11	Melanoma (Melanoma, Malignant) 01/2021 - 01/2002
7	Lymphopenia (Lymphocytopenia) 06/2013 - 02/2008
6	Bites and Stings (Sting) 01/2022 - 07/2011
6	Breast Neoplasms (Breast Cancer) 01/2019 - 02/2002
5	Astrocytoma (Pilocytic Astrocytoma) 01/2019 - 01/2006
5	Carcinogenesis 01/2017 - 01/2011
4	Poliomyelitis (Polio) 01/2021 - 11/2014
4	Infections 01/2021 - 02/2009
4	Inflammation (Inflammations) 01/2021 - 11/2016
4	Hypersensitivity (Allergy) 03/2011 - 04/2009
4	Oligodendroglioma 12/2009 - 01/2006
3	Neoplasm Metastasis (Metastasis) 01/2019 - 01/2016
3	Lung Neoplasms (Lung Cancer) 01/2018 - 08/2004
3	Hypoxia (Hypoxemia) 01/2016 - 08/2006
2	Disease Progression 01/2021 - 10/2005
2	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 11/2016
2	Head and Neck Neoplasms (Head and Neck Cancer) 09/2014 - 09/2006

Drug/Important Bio-Agent (IBA)

43	ErbB Receptors (EGF Receptor)IBA 01/2019 - 01/2002
40	epidermal growth factor receptor VIIIIBA 01/2019 - 01/2002
29	Proteins (Proteins, Gene)FDA Link 01/2019 - 05/2003
29	Monoclonal AntibodiesIBA 01/2016 - 01/2002
22	Temozolomide (Temodar)FDA LinkGeneric 01/2016 - 09/2002
20	AntigensIBA 01/2020 - 01/2002
16	Immunotoxins (Immunotoxin)IBA 01/2019 - 01/2005
16	VaccinesIBA 01/2018 - 02/2002
11	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2019 - 02/2009
9	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 09/2002
8	Pharmaceutical PreparationsIBA 01/2018 - 09/2007
8	Biological ProductsIBA 12/2013 - 05/2005
8	Peptides (Polypeptides)IBA 03/2013 - 01/2002
7	EnzymesIBA 01/2019 - 02/2006
7	Phosphotransferases (Kinase)IBA 12/2015 - 12/2004
7	Irinotecan (Camptosar)FDA LinkGeneric 06/2011 - 09/2002
7	O(6)-benzylguanineIBA 10/2009 - 05/2002
7	Carmustine (FIVB)FDA Link 08/2009 - 05/2002
6	MethyltransferasesIBA 01/2022 - 10/2005
6	Neoplasm Antigens (Tumor Antigens)IBA 01/2020 - 05/2009
6	CytokinesIBA 01/2016 - 06/2004
6	Bevacizumab (Avastin)FDA Link 06/2011 - 08/2006
5	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2019 - 04/2013
5	Biomarkers (Surrogate Marker)IBA 01/2018 - 03/2009
5	Single-Chain AntibodiesIBA 01/2018 - 01/2006
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2017 - 08/2006
5	D2C7-(scdsFv)-PE38KDELIBA 04/2017 - 09/2013
5	NADP (NADPH)IBA 01/2013 - 02/2009
5	N-succinimidyl 4-guanidinomethyl-3-iodobenzoateIBA 10/2010 - 01/2002
5	Alkyl and Aryl TransferasesIBA 02/2009 - 09/2002
5	Tyrosine Kinase InhibitorsIBA 11/2005 - 11/2002
4	poliovirus receptorIBA 01/2021 - 07/2004
4	MicroRNAs (MicroRNA)IBA 01/2016 - 01/2011
4	RNA (Ribonucleic Acid)IBA 10/2015 - 03/2015
4	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2013 - 11/2002
4	isocitric acid (isocitrate)IBA 12/2012 - 02/2009
4	Oxidoreductases (Dehydrogenase)IBA 12/2012 - 02/2009
4	Cytotoxins (Cytolysins)IBA 01/2012 - 02/2007
4	Glycoproteins (Glycoprotein)IBA 07/2011 - 04/2006
4	TenascinIBA 05/2007 - 08/2004
4	Gefitinib (Iressa)FDA Link 02/2006 - 11/2002
3	Messenger RNA (mRNA)IBA 01/2018 - 04/2006
3	ProteomeIBA 01/2018 - 10/2009
3	ExotoxinsIBA 04/2017 - 10/2003
3	alpha-hydroxyglutarateIBA 01/2017 - 02/2011
3	Chimeric Antigen ReceptorsIBA 03/2016 - 01/2014
3	Tyrosine (L-Tyrosine)FDA Link 12/2015 - 06/2007
3	Antineoplastic Agents (Antineoplastics)IBA 12/2013 - 11/2012
3	GangliosidesIBA 09/2013 - 01/2010
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 03/2013 - 02/2006
3	Amino Acids FDA Link 01/2013 - 04/2006
3	Protein Subunit VaccinesIBA 01/2013 - 02/2008
3	1,3,4,6-tetrachloro-3 alpha,6 alpha-diphenylglycolurilIBA 01/2012 - 05/2003
3	Human Serum Albumin FDA LinkGeneric 09/2011 - 02/2007
3	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2011 - 01/2005
3	Heat-Shock Proteins (Heat-Shock Protein)IBA 10/2009 - 05/2006
3	Transforming Growth Factor beta (TGF-beta)IBA 05/2009 - 06/2004
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2019
2	A-factor (Streptomyces)IBA 01/2019 - 01/2011
2	chondroitin sulfate proteoglycan 4IBA 01/2019 - 01/2017
2	Therapeutic UsesIBA 01/2018 - 08/2009
2	Formaldehyde (Formol)FDA Link 12/2017 - 01/2016
2	ParaffinIBA 12/2017 - 01/2016
2	AntibodiesIBA 01/2017 - 08/2010
2	ChemokinesIBA 11/2016 - 03/2015
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2016 - 01/2006
2	Conditioned Culture MediaIBA 01/2016 - 08/2006
2	rindopepimutIBA 06/2015 - 03/2013
2	Membrane Proteins (Integral Membrane Proteins)IBA 09/2014 - 04/2006
2	Granzymes (Granzyme)IBA 12/2013 - 09/2013
2	Lysine (L-Lysine)FDA Link 11/2013 - 10/2012

Therapy/Procedure

79	Therapeutics 01/2021 - 08/2003
30	Immunotherapy 01/2021 - 02/2002
22	Drug Therapy (Chemotherapy) 01/2019 - 01/2004
10	Radiotherapy 07/2013 - 06/2005
4	Radioimmunotherapy 05/2007 - 09/2005
3	Catheters 12/2018 - 02/2007
2	Chemoradiotherapy 01/2016 - 01/2011